LandBridge Co. LLC LB 深 沪
已收盘 12-12 16:00:00 美东时间
55.21
-1.290
-2.28%
华盛通- 最 高57.225
- 今 开56.92
- 成交量 39.48万股
- 最 低 55.21
- 昨 收 56.50
- 总市值 13.99亿
- 52周最高 87.2968
- 市盈率 静 192.37
- 换手率 1.56%
- 52周最低 48.35
- 委 比 33.33%
- 总股本 2533.70万
- 历史最高 87.2968
- 量 比 1.60
- 振 幅 3.57%
- 历史最低 18.25
- 每 手 1
- 风险率 8.92%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多LandBridge Signs Agreements with Samsung C&T Renewables For Two BESS Projects Totaling 350 MW In Texas
Agreements provide options to lease acreage for two potential Battery Energy Storage System projects with aggregate capacity of 350 MW.LandBridge Company LLC (NYSE:LB, NYSE Texas: LB))) ("LandBridge" or the "Company")
12-11 21:38
Earnings Scheduled For December 5, 2025
Companies Reporting Before The Bell • MoneyHero (NASDAQ:MNY) is projected to re...
12-05 19:11
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
11-25 10:27
Piper Sandler Maintains Neutral on LandBridge, Raises Price Target to $65
Piper Sandler analyst Mark Lear maintains LandBridge (NYSE:LB) with a Neutral and raises the price target from $55 to $65.
11-25 01:04
LandBridge Announces Public Sale of 2.5M Shares by Major Stakeholder
LandBridge Company LLC (NYSE:LB) ("LandBridge" or the "Company") today announced the commencement of an underwritten public offering of 2,500,000 Class A shares representing limited liability company interests ("Class A
11-17 19:40
LandBridge shares are trading lower after the company reported worse-than-expected Q3 financial results.
LandBridge shares are trading lower after the company reported worse-than-expec...
11-13 22:21
LandBridge Q3 Sales $50.831M Miss $51.807M Estimate
LandBridge (NYSE:LB) reported quarterly sales of $50.831 million which missed the analyst consensus estimate of $51.807 million by 1.88 percent. This is a 78.44 percent increase over sales of $28.487 million the same
11-13 05:57
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
Savara prices $130M equity at $4.20
Clinical stage biopharmaceutical company focused on rare respiratory diseases—Savara (SVRA) priced an underwritten public offering of ~23.81M shares at a price of $4.20 per share. Total gross proceeds...
10-30 15:35
创新药大幅回调，发生了什么？港股通创新药ETF(159570)跌超2.5%，盘中持续溢价！机构：阶段加速调整后机会凸显！创新药三大支柱是什么？
今日（10.30），大盘午后震荡回调，创新药再度走低，再创阶段新低。100%创新药含量的港股通创新药ETF（159570）回调2.52%，盘中成交额大幅放量，已...
10-30 14:55
